Cited by 125Cancer Cells and MetastasisAngiogenesis and VEGF in CancerCancer, Lipids, and Metabolism

The DOI matches its Crossref record; 79 of the 81 references it cites were found in a registry or an index.

Oncogenic KRAS Drives Lipofibrogenesis to Promote Angiogenesis and Colon Cancer Progression

Open access

Hsu, Wen-Hao, LaBella, Kyle A., Lin, Yiyun, Xu, Ping, Lee, Rumi, Hsieh, Cheng-En, Yang, Lei, Zhou, Ashley, Blecher, Jonathan M., Wu, Chang-Jiun, Lin, Kangyu, Shang, Xiaoying, Jiang, Shan, Spring, Denise J., Xia, Yan, Chen, Peiwen, Shen, John Paul, Kopetz, Scott, DePinho, Ronald A.·2023·Cancer Discovery

DOI 10.1158/2159-8290.cd-22-1467PMC PMC10807546

Published version of a preprint

Open this paper in CoChat — free account Open PDF

Abstract

Oncogenic KRAS (KRAS*) contributes to many cancer hallmarks. In colorectal cancer, KRAS* suppresses antitumor immunity to promote tumor invasion and metastasis. Here, we uncovered that KRAS* transforms the phenotype of carcinoma-associated fibroblasts (CAF) into lipid-laden CAFs, promoting angiogenesis and tumor progression. Mechanistically, KRAS* activates the transcription factor CP2 (TFCP2) that upregulates the expression of the proadipogenic factors BMP4 and WNT5B, triggering the transformation of CAFs into lipid-rich CAFs. These lipid-rich CAFs, in turn, produce VEGFA to spur angiogenesis. In KRAS*-driven colorectal cancer mouse models, genetic or pharmacologic neutralization of TFCP2 reduced lipid-rich CAFs, lessened tumor angiogenesis, and improved overall survival. Correspondingly, in human colorectal cancer, lipid-rich CAF and TFCP2 signatures correlate with worse prognosis. This work unveils a new role for KRAS* in transforming CAFs, driving tumor angiogenesis and disease progression, providing an actionable therapeutic intervention for KRAS*-driven colorectal cancer. Significance: This study identified a molecular mechanism contributing to KRAS*-driven colorectal cancer progression via fibroblast transformation in the tumor microenvironment to produce VEGFA driving tumor angiogenesis. In preclinical models, targeting the KRAS*–TFCP2–VEGFA axis impaired tumor progression, revealing a potential novel therapeutic option for patients with KRAS*-driven colorectal cancer. This article is featured in Selected Articles from This Issue, p. 2489

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1158/2159-8290.cd-22-1467

Cites

79 of 79 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Fiji: an open-source platform for biological-image analysis
Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T., Preibisch, S., Rueden, C., Saalfeld, S., Schmid, B., et al. (2012) · Nature Methods · doi:10.1038/nmeth.2019 · Cited by 66,890
NIH Image to ImageJ: 25 years of image analysis
Schneider, C. A., Rasband, W. S., & Eliceiri, K. W. (2012) · Nature Methods · doi:10.1038/nmeth.2089 · Cited by 64,638
Cancer statistics, 2022
Siegel, R. L., Miller, K. D., Fuchs, H. E., & Jemal, A. (2022) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21708 · Cited by 17,196
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
Improved vectors and genome-wide libraries for CRISPR screening
Sanjana, N. E., Shalem, O., & Zhang, F. (2014) · Nature Methods · doi:10.1038/nmeth.3047 · Cited by 5,239
The biology and function of fibroblasts in cancer
Kalluri, R. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.73 · Cited by 4,366
The Genomic Landscapes of Human Breast and Colorectal Cancers
Wood, L. D., Parsons, D. W., Jones, S., Lin, J., Sjöblom, T., Leary, R. J., Shen, D., Boca, S. M., Barber, T., Ptak, J., et al. (2007) · Science · doi:10.1126/science.1145720 · Cited by 2,833
CHOPCHOP v3: expanding the CRISPR web toolbox beyond genome editing
Labun, K., Montague, T. G., Krause, M., Cleuren, Y. N. T., Tjeldnes, H., & Valen, E. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz365 · Cited by 2,075
Type 2 alveolar cells are stem cells in adult lung
Barkauskas, C. E., Cronce, M. J., Rackley, C. R., Bowie, E. J., Keene, D. R., Stripp, B. R., Randell, S. H., Noble, P. W., & Hogan, B. L. M. (2013) · Journal of Clinical Investigation · doi:10.1172/jci68782 · Cited by 1,776
Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer
Costa, A., Kieffer, Y., Scholer-Dahirel, A., Pelon, F., Bourachot, B., Cardon, M., Sirven, P., Magagna, I., Fuhrmann, L., Bernard, C., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.01.011 · Cited by 1,705

Show all 81 references

Sorted by citations

Tumor cell-intrinsic epigenetic dysregulation shapes cancer-associated fibroblasts heterogeneity to metabolically support pancreatic cancer
Niu, N., Shen, X., Wang, Z., Chen, Y., Weng, Y., Yu, F., Tang, Y., Lu, P., Liu, M., Wang, L., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.03.005 · Cited by 244
Cancer associated fibroblasts and metabolic reprogramming: unraveling the intricate crosstalk in tumor evolution
Zhang, F., Ma, Y., Li, D., Wei, J., Chen, K., Zhang, E., Liu, G., Chu, X., Liu, X., Liu, W., et al. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01600-2 · Cited by 178
CAF-induced physical constraints controlling T cell state and localization in solid tumours
Arpinati, L., Carradori, G., & Scherz‐Shouval, R. (2024) · Nature reviews. Cancer · doi:10.1038/s41568-024-00740-4 · Cited by 162
The roles of KRAS in cancer metabolism, tumor microenvironment and clinical therapy
Ma, Q., Zhang, W., Wu, K., & Shi, L. (2025) · Molecular Cancer · doi:10.1186/s12943-024-02218-1 · Cited by 101
The Role of KRAS Mutations in Colorectal Cancer: Biological Insights, Clinical Implications, and Future Therapeutic Perspectives
Takeda, M., Yoshida, S., Inoue, T., Sekido, Y., Hata, T., Hamabe, A., Ogino, T., Miyoshi, N., Uemura, M., Yamamoto, H., et al. (2025) · Cancers · doi:10.3390/cancers17030428 · Cited by 82
“These lipid-enriched CAFs produce VEGFA, fostering angiogenesis and supporting tumor growth [26].”
Functional heterogeneity of fibroblasts in primary tumors and metastases
Cheng, P. S. W., Zaccaria, M., & Biffi, G. (2024) · Trends in cancer · doi:10.1016/j.trecan.2024.11.005 · Cited by 78
Targeting KRAS: from metabolic regulation to cancer treatment
Shi, Y., Zheng, H., Wang, T., Zhou, S., Zhao, S., Li, M., & Cao, B. (2025) · Molecular Cancer · doi:10.1186/s12943-024-02216-3 · Cited by 81
The tumor microenvironment is an ecosystem sustained by metabolic interactions
Kay, E. J., & Zanivan, S. R. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115432 · Cited by 63
The fibroinflammatory response in cancer
Xiao, Z., & Puré, E. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-025-00798-8 · Cited by 65
TRIM21 induces selective autophagic degradation of c-Myc and sensitizes regorafenib therapy in colorectal cancer
Ye, W.-L., Huang, L., Yang, X., Wan, S., Gan, W.-J., Yang, Y., He, X., Liu, F., Guo, X., Liu, Y.-X., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2406936121 · Cited by 50
Cancer-associated fibroblasts promote proliferation, angiogenesis, metastasis and immunosuppression in gastric cancer
Li, P., Zhang, H., Chen, T., Zhou, Y., Yang, J., & Zhou, J. (2024) · Matrix Biology · doi:10.1016/j.matbio.2024.06.004 · Cited by 45
Theoretical framework and emerging challenges of lipid metabolism in cancer
Gu, Q., Wang, Y., Yi, P., & Cheng, C. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.12.002 · Cited by 45
METTL1 mediates PKM m7G modification to regulate CD155 expression and promote immune evasion in colorectal cancer
Wang, F., Yang, C., Zheng, F., Yang, Y., Li, G., Feng, Y., Xu, H., He, Z., Cai, D., Sun, H., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05991-1 · Cited by 43
Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
Ben‐Shmuel, A., Gruper, Y., Halperin, C., Levi-Galibov, O., Rosenberg-Fogler, H., Barki, D., Carradori, G., Stein, Y., Yagel, G., Naumova, M., et al. (2025) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-0131 · Cited by 50
Cancer-associated fibroblasts in the tumor microenvironment: heterogeneity, crosstalk mechanisms, and therapeutic implications
Huang, Z., Chen, J., Zhu, T., Li, J., Ng, H. Y., Zhou, Y., Gu, X., Xu, S., & Jia, R. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02533-1 · Cited by 49
Neutrophil extracellular traps in tumor metabolism and microenvironment
Liu, Z., Dou, Y., Lu, C., Han, R., & He, Y. (2025) · Biomarker Research · doi:10.1186/s40364-025-00731-z · Cited by 35
Nano-drug delivery strategies affecting cancer-associated fibroblasts to reduce tumor metastasis
Zou, L., Xian, P., Pu, Q., Song, Y., Ni, S., Chen, L., & Hu, K. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.02.040 · Cited by 28
Plasticity and Functional Heterogeneity of Cancer-Associated Fibroblasts
Flynn, J. M., Thadani, N., Gallagher, E. E., Azzaro, I., Bodnar, C. M., McCarty, C. P., Romano, G., Webster, M. R., & Capparelli, C. (2025) · Cancer Research · doi:10.1158/0008-5472.can-24-3037 · Cited by 30
Insights into the relevance of targeting fibroblasts to control cancer
Boeker, V., & Kalluri, R. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102395 · Cited by 25
Advancements in NSCLC
Xu, J., Tian, L., Qi, W., Lv, Q., & Wang, T. (2024) · American Journal of Clinical Oncology · doi:10.1097/coc.0000000000001088 · Cited by 29
Engineered CAF-cancer cell hybrid membrane biomimetic dual-targeted integrated platform for multi-dimensional treatment of ovarian cancer
Yao, Y., Zhang, J., Huang, K., Peng, Y., Cheng, S., Liu, S., Zhou, T., Chen, J.-H., Li, H., Zhao, Y., et al. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03165-9 · Cited by 25
CAFs vs. TECs: when blood feuds fuel cancer progression, dissemination and therapeutic resistance
Coursier, D., & Calvo, F. (2024) · Cellular Oncology · doi:10.1007/s13402-024-00931-z · Cited by 23
Immunomodulatory molecules in colorectal cancer liver metastasis
Kong, W.-S., Li, J.-J., Deng, Y., Ju, H., & Xu, R. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217113 · Cited by 21
Macrophage heterogeneity and its interactions with stromal cells in tumour microenvironment
Cao, L., Meng, X., Zhang, Z., Liu, Z., & He, Y. (2024) · Cell & Bioscience · doi:10.1186/s13578-024-01201-z · Cited by 28
Systematic analysis of human colorectal cancer scRNA-seq revealed limited pro-tumoral IL-17 production potential in gamma delta T cells
Ran, R., Trapečar, M., & Brubaker, D. K. (2024) · Neoplasia · doi:10.1016/j.neo.2024.101072 · Cited by 19
Single‐Cell RNA Sequencing Identifies MMP11 + Cancer‐Associated Fibroblasts as Drivers of Angiogenesis and Bladder Cancer Progression
Xu, W., Liang, T., Hu, F., Fu, L., Deng, D., Tan, X., Liu, L., Tang, D., Zheng, H., Ding, Q., et al. (2025) · Advanced Science · doi:10.1002/advs.202502774 · Cited by 21
Lipid metabolism reprogramming shapes the immune landscape in the tumor microenvironment
Du, Y., Cai, Z.-R., Duan, X.-T., Li, X., Yue, T., Tian, T., Li, J.-J., & Ju, H. (2026) · Cellular and Molecular Immunology · doi:10.1038/s41423-026-01411-0 · Cited by 24
NEIL1 drives the initiation of colorectal cancer through transcriptional regulation of COL17A1
Cao, J., Cao, C., Lin, J., Li, S., He, L., Han, K., Chen, J., Li, S., Wang, X., Xie, D., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2023.113654 · Cited by 19
Cancer-associated fibroblast secreted DKK1 promotes the immunosuppressive tumor microenvironment and colorectal cancer resistance to chemotherapy
Yin, Z., Zhou, Y., Zhu, X., Goettl, R. A., Wang, C., Weiss, H. L., Evers, B. M., & Wang, Q. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.218060 · Cited by 18
Mechanistic Foundations of KRAS‐Driven Tumor Ecosystems: Integrating Crosstalk among Immune, Metabolic, Microbial, and Stromal Microenvironment
Ma, J., Fu, S., Tan, J., Han, Y., Chen, Y., Deng, X., Shen, H., Zeng, S., Peng, Y., & Cai, C. (2025) · Advanced Science · doi:10.1002/advs.202502714 · Cited by 17
Siglec‐G Suppresses CD8 + T Cells Responses through Metabolic Rewiring and Can be Targeted to Enhance Tumor Immunotherapy
Yin, S., Li, C., Shen, X., Yu, G., Cui, L., Wu, Y., He, Y., Yu, S., Chen, J., Lu, S., et al. (2024) · Advanced Science · doi:10.1002/advs.202403438 · Cited by 15
CAF-mediated tumor vascularization: From mechanistic insights to targeted therapies
Zhang, Z., Zhang, Q. H., & Wang, Y. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.111827 · Cited by 17
Cancer-associated fibroblasts: central players in cancer hallmarks and therapeutic resistance
Lu, Y., Wu, Y., Xu, X., Feng, Y., & Wang, N. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02516-1 · Cited by 17
Metabolic reprogramming in KRAS-mutant cancers: Proven targetable vulnerabilities and potential therapeutic strategies
Wu, R., Zhu, H., He, Q., Yuan, T., & Yang, B. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.104220 · Cited by 14
Cancer-associated fibroblasts as key regulators of lipid metabolism in the tumour microenvironment
Adams, J., Suelzu, C. M., Strusi, G., & Stebbing, J. (2026) · Oncogene · doi:10.1038/s41388-026-03733-9 · Cited by 13
Cancer cell – Fibroblast crosstalk via HB-EGF, EGFR, and MAPK signaling promotes the expression of macrophage chemo-attractants in squamous cell carcinoma
Giangreco, G., Rullan, A., Naito, Y., Biswas, D., Liu, Y.-H., Hooper, S., Nenclares, P., Bhide, S. A., Cheang, M. C. U., Chakravarty, P., et al. (2024) · iScience · doi:10.1016/j.isci.2024.110635 · Cited by 13
CRCs-CAFs crosstalk-targeted nano-delivery system reprograms tumor microenvironment for oxaliplatin resistance reversing and liver metastasis inhibition in colorectal cancer
Liu, H., Xu, C., Wang, P., Guo, L., Yan, X., Zhou, R., Tang, Y., Wang, S., Chen, J., Wang, Q., et al. (2025) · Bioactive Materials · doi:10.1016/j.bioactmat.2025.08.002 · Cited by 12
Host and microbiome lipid metabolism in colorectal cancer development and therapy
Evora, G. M., Brauer, M., & Letellier, E. (2025) · Trends in cancer · doi:10.1016/j.trecan.2025.08.005 · Cited by 16
POSTN + CAF-Derived Migrasomes Drive Hepatocellular Carcinoma Progression and Confer Resistance to Immunotherapy
Zhu, Z., Zhang, K., Wu, W., Zhou, J., Zhang, M., Chen, J., Han, J., Wang, N., Li, B., Weng, W., et al. (2025) · Research · doi:10.34133/research.0950 · Cited by 12
Tumor-associated macrophages enhance peripheral nerve tumor infiltration and spinal cord repair
Dolci, S., Mannino, L., Rossi, E., Bottani, E., Ciarpella, F., Piazza, N., Karkossa, I., Chio, M. D., Savino, B., Lucidi, B., et al. (2026) · Immunity · doi:10.1016/j.immuni.2025.12.016 · Cited by 14
SOS1 inhibitor BI-3406 shows in vivo antitumor activity akin to genetic ablation and synergizes with a KRAS G12D inhibitor in KRAS LUAD
Baltanás, F. C., Kramer‐Drauberg, M., García‐Navas, R., Patrucco, E., Petrini, E., Arnhof, H., Juan, A. O.-S., Rodríguez-Ramos, P., Borrajo-Sánchez, J., Calzada, N., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2422943122 · Cited by 16
Emerging trends and converging evidence in tumor evolution: A comprehensive review
Jin, C., Li, W., Liu, B., Cao, L.-Q., Stefan, S. M., Yuan, L., Yu, X., Shi, L., & Yu, H. (2026) · Drug Resistance Updates · doi:10.1016/j.drup.2026.101380 · Cited by 12
Metformin induces apoptosis in TRAIL-resistant colorectal cancer cells
Lee, D. E., Lee, H. M., Ye, J., Choi, S. Y., Lee, S. J., & Kwon, O. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2024.119873 · Cited by 11
Single-cell and spatial transcriptome profiling identifies the immunosuppressive spatial niche in KRAS -mutant colorectal cancer
Yang, S., Gu, C., Miao, X., Zuo, H., Xu, W. L., Zhang, Y., Tang, W., Zhu, J., Yuan, Z., Gu, X., et al. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2025-013763 · Cited by 11
Characterization of metastasis-specific macrophages in colorectal cancer for prognosis prediction and immunometabolic remodeling
Yang, H., Ma, X., Zhao, X., Wei, X., Mu, X., & Zhang, X. (2024) · Scientific Reports · doi:10.1038/s41598-024-77248-2 · Cited by 11
Resistance to oncolytic virotherapy: Multidimensional mechanisms and therapeutic breakthroughs (Review)
Xu, J., Xia, Z., Wang, S., & Xia, Q. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5612 · Cited by 11
MC1R regulates T regulatory cell differentiation through metabolic reprogramming to promote colon cancer
Zhu, S., Zou, M., Li, C., Tang, Y., Luo, H., & Dong, X. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112546 · Cited by 9
Single cell analysis reveals that SPP1+ macrophages enhance tumor progression by triggering fibroblast extracellular vesicles
Wang, H., Qiu, B., Li, X., Ying, Y., Wang, Y., Chen, H., Zeng, F., Shi, J., Huang, J., Wu, Z., et al. (2025) · Translational Oncology · doi:10.1016/j.tranon.2025.102347 · Cited by 13
Targeting lipid metabolism to enhance cancer immunotherapy
Zhao, D., Wu, L., & Li, Y. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189416 · Cited by 11
Role of metabolic reprogramming of cancer‑associated fibroblasts in tumor development and progression (Review)
Li, R., & Li, Y. (2025) · International Journal of Oncology · doi:10.3892/ijo.2025.5796 · Cited by 9
Cancer-associated fibroblasts: Recent advances and therapeutic implications
Paraskeva, C., Stavropoulou, A., & Koliaraki, V. (2025) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2025.102601 · Cited by 9
TFCP2 as a therapeutic nexus: unveiling molecular signatures in cancer
Kaushik, N., Jaiswal, A., Bhartiya, P., Choi, E. H., & Kaushik, N. K. (2024) · Cancer and Metastasis Reviews · doi:10.1007/s10555-024-10175-w · Cited by 7
Integration of Untargeted Metabolomics, Network Pharmacology, Single-Cell RNA Sequencing, and Molecular Dynamics Simulation Reveals GOT1, CYP1A2, and CA2 as Potential Targets of Huang Qin Decoction Preventing Colorectal Cancer Liver Metastasis
Li, T., Yan, Z., Zhou, M., Zhao, W., Zhang, F., Lv, S., Hou, Y., Zeng, Z., Liu, Y., Zhou, Y., et al. (2025) · Pharmaceuticals · doi:10.3390/ph18071052 · Cited by 8
GSDMB interacts with IGF2BP1 to suppress colorectal cancer progression by modulating DUSP6-ERK pathway
Jiang, H., Deng, L., Lin, Z., Yang, K., Yang, J., Zhao, W., & Gong, W. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113280 · Cited by 8
Single-cell and bulk RNA-sequencing reveal PRRX2-driven cancer-associated fibroblast-mediated perineural invasion for predicting the immunotherapy outcome in colorectal cancer
Chen, M., Cai, Y., Han, F., Li, B., Zhou, X., Cui, K., Bai, W., & Li, F. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1620388 · Cited by 8
The Spatiotemporal Heterogeneity of Tumor-Associated Stromal Cells: Reprogramming Plasticity to Unlock Precision Cancer Immunotherapy
Lv, Y., Duan, T., Song, J., Liu, S., Zhou, Z., Ba, Y., Weng, S., Zuo, A., Xu, H., Luo, P., et al. (2026) · 癌症：英文版 · doi:10.34133/cancomm.0002 · Cited by 7
Consensus clustering and development of a risk signature based on trajectory differential genes of cancer-associated fibroblast subpopulations in colorectal cancer
Yu, K., Wang, J., Wang, Y., He, J., Hu, S., & Kuai, S. (2024) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-024-05906-z · Cited by 6
Identification of cancer-associated fibroblast signature genes for prognostic prediction in colorectal cancer
Wei, J., Lu, Y., Lu, J., Wang, Z., Yan, Y., Liang, B., Qian, S., Ni, J., Yang, Y., Huang, S., et al. (2025) · Frontiers in Genetics · doi:10.3389/fgene.2025.1476092 · Cited by 6
Neoadjuvant chemotherapy combined with bevacizumab for resectable colorectal liver metastasis with risk factors for recurrence: a multicenter real-world study
Chen, Y., Zheng, Y., Wu, J., Ye, R., Jia, H., Zhou, Z., Chen, W., Xu, L., Zhang, Y., & Zheng, M. (2025) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359251328457 · Cited by 6
Colorectal Cancer Cells–Derived Exosomal PIK3CA Mutation DNA Promotes Tumor Metastasis by Activating Fibroblast and Affecting Tumor Metastatic Microenvironment
Wang, R. Y., Li, W., Lv, Y., Ba, W., Jiang, Y., Li, X., & Jin, F. (2025) · Advanced Science · doi:10.1002/advs.202501792 · Cited by 6
Integrated Single-Cell Analysis Reveals the Heterogeneity of Tumor-Associated Macrophages and Their Implications for Immunotherapy in Colorectal Cancer
Xu, G., Fang, B., Tang, X., Wei, Q., & Li, J. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s531641 · Cited by 5
Antibody–Drug Conjugates Targeting Resistance-Associated Signaling Pathways: Recent Advances and Future Perspectives
Xie, D., Yang, C. C.-K., Gao, S., Li, J., Yang, J., Li, X., Jiang, R., Cao, F., Zhang, S., Wang, L., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27073287 · Cited by 5
The Significance of the Heterogeneity of Cancer-Associated Fibroblasts in Tumor Microenvironments
Imanishi, D., Nishikubo, H., Ma, D., Gao, H., Sano, T., Fan, C., Sakuma, T., Yamamoto, Y., & Yashiro, M. (2026) · Metabolites · doi:10.3390/metabo16020120 · Cited by 4
Decoding the Plasticity of Cancer‐Associated Fibroblasts: Mechanistic Insights and Precision Targeting Strategies in Gastric Cancer Progression and Therapeutic Resistance
Deng, S., Chen, Y. Z., & Du, J. (2025) · Cell Proliferation · doi:10.1111/cpr.70094 · Cited by 4
Pharmacological SOS1 inhibitor BI-3406 demonstrates in vivo anti-tumor activity comparable to SOS1 genetic ablation in KRAS mutant tumorsPreprint
Baltanás, F. C., Kramer‐Drauberg, M., García‐Navas, R., Patrucco, E., Petrini, E., Arnhof, H., Juan, A. O.-S., Rodríguez-Ramos, P., Borrajo, J., Calzada, N., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.18.613686 · Cited by 4
Single-cell sequencing reveals dysregulated cell type perturbations and critical mediator communication remodelling in colorectal cancer
Xu, C., Zhang, S., Zhang, Z., Zhang, L., Sun, B., Yu, Z., & Liu, H. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1557564 · Cited by 3
KRAS mutations in colorectal cancer: impacts on tumor microenvironment and therapeutic implications
Emami, A., Sharif, P. M., & Rezaei, N. (2025) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2025.2500426 · Cited by 3
Elucidation of novel diagnostic biomarkers and therapeutic targets in colorectal carcinoma: an integrative approach leveraging multi-omics, computational biology, and single-cell sequencing technologies
Li, T., Tian, Y., Wang, Y., Yang, J., Chen, Z., & Li, Y. (2025) · Mammalian Genome · doi:10.1007/s00335-025-10141-z · Cited by 3
CYP1B1 Knockout in a Bovine Hepatocyte-like Cell Line (BFH12) Unveils Its Role in Liver Homeostasis and Aflatoxin B1-Induced Hepatotoxicity
Iori, S., Montanucci, L., D’Onofrio, C., Lahtela-Kakkonen, M. K., Lucatello, L., Bardhi, A., Barbarossa, A., Capolongo, F., Zaghini, A., Pauletto, M., et al. (2025) · Toxins · doi:10.3390/toxins17060294 · Cited by 2
A ligand-centered framework for γδ T cell activation in colorectal cancer revealed by single-cell and transformer-based perturbation
Ran, R., & Brubaker, D. K. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1715827 · Cited by 2
The DAG/PKC/CREB1/TGF-β1 axis drives shear-wave elastography stiffness and malignant progression in triple-negative breast cancer via lipid metabolic reprogramming
Wang, S., Zheng, D., Wang, Z., Hou, R., Zhang, Z., You, Z., Zhou, J., Huang, Y., Quan, M., Zhou, J., et al. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08625-0 · Cited by 2
One Mutation to Rule Them All: Mutant KRAS Controls Tumor Intrinsic and Microenvironment Signaling
Müller, S., & Krishnamurty, A. T. (2023) · Cancer Research · doi:10.1158/0008-5472.can-23-3682 · Cited by 2
Tumor-associated macrophages enhance tumor innervation and spinal cord repairPreprint
Dolci, S., Mannino, L., Campanelli, A., Rossi, E., Bottani, E., Ciarpella, F., Karkossa, I., Setten, E., Savino, B., Pruonto, G., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.19.629374 · Cited by 2
ENTR1 affects the progression of colon cancer by regulating energy metabolism under the influence of glycolysis
Ma, A., Zhai, C., He, Q., Wang, W., Ren, H., Mao, K., Lan, W., & Lan, J. (2025) · BMC Cancer · doi:10.1186/s12885-025-14412-5 · Cited by 1
Expression of serum HMGB1, SAA, and TSGF in patients with colon cancer and the value of prognostic assessment
Wang, K., & Huang, J. (2025) · Cancer Biomarkers · doi:10.1177/18758592241297848 · Cited by 1
FAP as a prognostic biomarker and radiomics-based predictor of angiogenesis-associated recurrence in Adamantinomatous craniopharyngioma
Huang, Q., Yan, X., Zhang, B., Liu, Z., Chen, Y., Liu, X., Li, M., Su, X., Wang, X., Wu, B., et al. (2025) · Pituitary · doi:10.1007/s11102-025-01552-x · Cited by 1
Analysis and prediction of serological indicators associated with colorectal interval polyposis after resection
Lan, Y., Zhang, L., & Li, R. J. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1634468 · Cited by 1
Multi-omics integration reveals CYTL1 and H6PD as key regulators of tumor metabolism in mesothelioma
Ma, J., Zhang, H., Yu, L., Guo, Y., Ming, J., & Guo, Z. (2025) · Genes & Genomics · doi:10.1007/s13258-025-01667-2 · Cited by 1
Pan-Immune-Inflammation Value (PIV) and Prognostic Nutritional Index (PNI) are Associated with Distant Metastasis in Colorectal Cancer with KRAS Mutation but Not in Those with KRAS Wild-Type
Li, Y., & Zeng, Y. (2025) · International Journal of General Medicine · doi:10.2147/ijgm.s541575 · Cited by 1
Presence of Adipophilin-Positive Cancer-Associated Fibroblasts Is an Independent Poor Prognostic Indicator and Is Correlated with Immature-Type Desmoplastic Reaction in Patients with Colorectal Cancer
Kobayashi, T., Ishida, M., Uehara, H., Shoichiro, I., Yamada, N., Igarashi, Y., Hagiwara, C., Mori, Y., Hirose, Y., & Watanabe, J. (2025) · Cancers · doi:10.3390/cancers17183006 · Cited by 1
KLF7 as a biomarker for the pre-metastatic state promotes colorectal cancer liver metastasis via TGFβ autocrine signaling
Fang, X., Huang, H., Zhao, Z., Yang, L. T., Huang, F., Li, J., Meng, Z., He, S., Li, T., Yang, S., et al. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.218123 · Cited by 1
Self-citation
LINC01063 promotes colon cancer progression via the miR-134-5p/KRAS axis and serves as a prognostic biomarker
Liu, Q., Sun, S., & Fan, R. (2025) · Discover Oncology · doi:10.1007/s12672-025-03961-7 · Cited by 1
Association between serum lipids and colorectal polyps: a retrospective cross-sectional study
He, M., Tian, S., Wang, S., & Huo, R. (2026) · International Journal of Colorectal Disease · doi:10.1007/s00384-025-05056-9 · Cited by 1
ABCA8-positive lipid-metabolic CAFs mediate immunotherapy resistance in TNBC
Qin, W., Li, D., Zhang, J., Wang, S., Hou, L., Zhang, C., Wang, D., & Zhang, J. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2025.1729275 · Cited by 2
Machine learning–driven transcriptomic and single-cell profiling of programed cell death patterns in colon cancer
Du, J.-O., Huang, Q., Sun, X.-C., Hu, S., & Lin, T. (2026) · Science Progress · doi:10.1177/00368504261432995 · Cited by 1
SOS1: tracking the evolving path from promising to actionable therapeutic target in RAS-dependent cancers
Luna-Ramírez, L., García‐Navas, R., Santos, E., & Baltanás, F. C. (2026) · Molecular Cancer · doi:10.1186/s12943-026-02632-7 · Cited by 3
Targeting the YAP-mediated stromal signaling unlocks chemoresistance in a human organoid fibrosis model
Xiong, D., Zheng, Q., Chen, W., Li, M., Chen, Y., Zhang, C., & Liu, J. (2026) · Biofabrication · doi:10.1088/1758-5090/ae6f84 · Cited by 1
A three-gene signature (ABCE1, ATAD5, FUT4) for colorectal cancer prognosis: integrative analysis of transcriptomic, single-cell, and machine learning data
Wang, Y., wang, T., He, J., Zhang, T., Jin, R., Chen, D., Hu, Z., Pang, Q., & Liu, H. (2026) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2026.154124 · Cited by 1
Cancer cell – fibroblast crosstalk via HB-EGF/EGFR/MEK signaling promotes macrophage recruitment in squamous cell carcinomaPreprint
Giangreco, G., Rullan, A., Naito, Y., Biswas, D., Liu, Y.-H., Hooper, S., Nenclares, P., Bhide, S. A., Cheang, M. C. U., Chakravarty, P., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.07.13.548733
WITHDRAWN: Oncogenic KRAS G12D extrinsically induces an immunosuppressive microenvironment in lung adenocarcinomaPreprint
Opsahl, E. L. L., Baliira, R. K., Barravecchia, I., McLintock, E., Lee, J. M., Ferris, S. F., Espinoza, C. E., Hinshaw, R., Cavanaugh, S., Robotti, M., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.16.568090
Genetic and serological markers in colorectal cancer surgery
Silaghi, A. M., Constantin, V. D., Şerban, D., Epistatu, D., Păunică, I., Bălan, D. G., & Rebegea, L. F. (2024) · Journal of Mind and Medical Sciences · doi:10.22543/2392-7674.1474
The diverse functions and therapeutic implications of cancer-associated fibroblasts in colorectal cancer
LAI, Z., ZHAO, H., & Deng, H. X. (2024) · Biocell · doi:10.32604/biocell.2024.053983
BATF is involved in the malignant phenotype and epithelial-mesenchymal transition of colon cancer cells via ERK/PD-L1 signaling.
Chen, X., Dong, H., & Jin, L. (2025) · PubMed · doi:10.14670/hh-18-823
Postoperative metastatic Krukenberg tumors with ARID1A and KRAS mutations in a patient with gastric cancer treated with oxaliplatin and tegafur: A case report
Wu, J., Jiang, S., Shen, Q., & Gong, H. (2025) · Oncology Letters · doi:10.3892/ol.2025.15008
Self-citation
Synergistic effects of Aurora A and AKT inhibitors combined with radiation in colon cancer cells
Peng, Q., We, Z., Li, J., & Liu, D. (2025) · Discover Oncology · doi:10.1007/s12672-025-02562-8
Single-Cell RNA Sequencing Reveals Characteristics of Myeloid Cells and Fibroblasts in RAS-Mutated Colorectal CancerPreprint
He, Q., Sheng, N., Wang, J., Gong, J., Gu, Y., Liu, Z., Jiao, Q., Chen, H., Zhang, Z., & Wang, Z. (2025) · Research Square · doi:10.21203/rs.3.rs-6741598/v1
Spatial Domain‐Based Approach to Analyze the Mechanism of Sparganii Rhizoma‐Curcumae Rhizoma Pair in the Treatment of Colorectal Cancer
Liu, Y., Ye, Q., Jin, Y., Zhang, Q., Zou, X., & Li, J. (2025) · Food Science & Nutrition · doi:10.1002/fsn3.70794
Exploring the pathogenic mechanism of RNH1 in colorectal cancer based on eQTL, Multi-omics and deep learning
Chen, C., Chen, X., Yang, Y., Cai, Y., Chen, N., Jiang, D., & Weng, Y. (2025) · Journal of Applied Genetics · doi:10.1007/s13353-025-01029-4 · Cited by 1
Single-cell omics in investigating the effect of CAFs with KRAS overexpression on the malignant progression of anaplastic thyroid cancer
Sun, H., Chen, Q., Li, G., Chen, M., Dai, J., & Yan, M. (2026) · Journal of the Chinese Medical Association · doi:10.1097/jcma.0000000000001334
Targeting TCF21-TCF3 heterodimer in tumor-associated pericytes attenuates hematogenous metastasis by restoring pericyte gatekeeper function
Yin, W., Yao, H., Xiaobo, L. I., Pan, W., Zhang, Y., Wang, C., Deng, L., Lin, C., Zhang, Z.-M., Pan, J., et al. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102569

Authors: Hsu, W.-H., LaBella, K. A., Lin, Y., Xu, P., Lee, R., Hsieh, C.-E., Yang, L., Zhou, A., Blecher, J. M., Wu, C.-J., Lin, K., Shang, X., Jiang, S., Spring, D. J., Xia, Y., Chen, P., Shen, J. P., Kopetz, S., & DePinho, R. A.
Affiliations: The University of Texas MD Anderson Cancer Center (US)
3Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
ORCID: Hsu, Wen-Hao
LaBella, Kyle A.
Lin, Yiyun
Xu, Ping
Lee, Rumi
Hsieh, Cheng-En
Yang, Lei
Zhou, Ashley
Blecher, Jonathan M.
Wu, Chang-Jiun
Lin, Kangyu
Shang, Xiaoying
Jiang, Shan
Spring, Denise J.
Xia, Yan
Chen, Peiwen
Shen, John Paul
Kopetz, Scott
DePinho, Ronald A.
Venue: Cancer Discovery
Publisher: American Association for Cancer Research (AACR)
Published: 2023-09-27
Volume: 13
Issue: 12
Pages: 2652-2673
ISSN: 2159-8274 (ISSN-L)
2159-8290
DOI: 10.1158/2159-8290.cd-22-1467
PMC: PMC10807546
OpenAlex: W4387115132
Cited by: 125
References: 81
Citations by year: 2026: 42 · 2025: 53 · 2024: 28 · 2023: 2
FWCI: 15.18
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Cancer Discovery (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Digital Commons-TMC (Texas Medical Center) (submittedVersion)
Funders: Cancer Prevention and Research Institute of Texas (RP210028)
National Institutes of Health (F99 CA274661, R01 CA231360)
Topics: Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
Keywords: oncogenic KRAS, colorectal cancer, cancer-associated fibroblasts, angiogenesis, VEGF-A, TFCP2, BMP4, Wnt5b, tumor microenvironment, tumor progression, antitumor immunity, prognostic signature, KRAS-targeted therapy
MeSH terms: Cancer-Associated Fibroblasts, Angiogenesis, Animals, Colonic Neoplasms, DNA-Binding Proteins, Fibroblasts, Humans, Lipids, Transcription Factors, Colorectal Neoplasms, Proto-Oncogene Proteins p21(ras), Mice, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Oncogenic KRAS Drives Lipofibrogenesis to Promote Angiogenesis and Colon Cancer Progression

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks